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Background: This study was performed to examine whether patients with type 2 diabetes have cognitive deficits
associated with the prefrontal cortex (PFC).
Methods: Twenty-seven middle-aged patients with newly diagnosed type 2 diabetes and 27 healthy controls
underwent physical measurements and neuropsychological tasks. Response inhibition, reward prediction, and
executive function were assessed by the Go/NoGo task, the reversal and extinction tasks, and the Wisconsin Card
Sorting Test (WCST). To examine the interactions of being overweight with diabetes on cognitive performance,
performance data were analysed by two-way ANCOVA with diabetes and overweight as factors and age as a
covariate.
Results: Patients with type 2 diabetes showed significantly decreased response inhibition in the Go/NoGo task
(discriminability index: P = 0.001). There was an interaction of being overweight with diabetes on reaction time in
the Go trials of the Go/NoGo task (P = 0.009). Being overweight was related to retained responses to the
presentiment of reward in the extinction task (P = 0.029). The four groups showed normal cognitive performance
in the WCST.
Conclusions: Our results showed that middle-aged, newly diagnosed and medication-free patients with type 2
diabetes have a particular neuropsychological deficit in inhibitory control of impulsive response, which is an
independent effect of diabetes apart from being overweight.
Background
Patients with type 2 diabetes are required to make strict
daily decisions for optimal glycemic control; for example,
they should resist the temptation of high-fat, high-calorie
diets and maintain daily exercise. Although lifestyle
improvement is necessary to avoid future complications
of diabetes [1], it is often difficult for people to change
their daily behaviors.
Previous studies indicated that the ventral PFC regulates
human decision making by predicting future rewards and
punishments [2,3] and inhibits impulsive thoughts and
responses with a distributed cortical network [4], whereas
the dorsolateral PFC regulates general cognitive functions
such as executive function [5]. Executive function plays a
key role in organization of information, carrying out plans,
judgment according to outcome and cognitive shifting. On
the other hand, many real-world situations elicit actions in
which immediate reward is a priority prior to delayed out-
come estimated by executive function. For example, over-
eating in response to environmental cues immediately
produces innate pleasure and reduces psychological dis-
tress, despite an awareness of future adverse physical out-
come. In such conditions, rapid reward prediction or
impulsive response to environmental stimuli prevails over
the preparations by executive function [2]. While there is
accumulating evidence suggesting poorer cognitive perfor-
mance in executive function in patients with type 2 dia-
betes compared to those without this disease [6-10], to
our knowledge, there has been only one report that
patients with type 2 diabetes had cognitive difficulty in
response inhibition [10]. This study used a comprehensive
neuropsychological test and found selective cognitive dete-
rioration in response inhibition. However, their patients
with type 2 diabetes were older adults (mean age = 68.59,
range = 55 to 81 years) with an average disease duration
of 8.29 years, 65.87% of whom were controlled by oral
medication and/or insulin. Therefore, the results regarding
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any medium, provided the original work is properly cited.cognitive performance in these patients with type 2 dia-
betes may have been affected by advanced age, disease
duration [6,11] and medication [12,13].
Recently, overweight and obese non-diabetic subjects
were reported to demonstrate excessive reward prediction
[14] and difficulties in inhibition of impulsive responses
[15]. Obesity is an important cofactor in type 2 diabetes
because the presence of obesity and diabetes together is
associated with more severe insulin and leptin resistance
than either condition alone. Insulin and leptin are impor-
tant central signals to regulate PFC functions [16], and
these central actions are attenuated in both obesity and
diabetes [16,17]. These findings suggest that weight gain
and type 2 diabetes may be related to interactive deteriora-
tion in cognitive function associated with PFC. In previous
studies of type 2 diabetes [6-10], overweight or obese dia-
betic subjects were not compared with normal-weight dia-
betic subjects, which made it difficult to determine the
independent effects of type 2 diabetes and being over-
weight and to examine the interaction of being overweight
with type 2 diabetes on cognitive function. In this study,
we recruited middle-aged, newly diagnosed and medica-
tion-free Japanese patients with type 2 diabetes. The aver-
age BMI of Japanese diabetic patients is normal compared
with the non-diabetic Japanese population [18]. We exam-
ined cognitive performance in four groups (overweight
patients with type 2 diabetes, normal-weight patients with
type 2 diabetes, overweight controls and normal-weight
controls), which allowed us to assess cognitive perfor-
mance using two-way ANOVA with diabetes and over-
weight as factors.
The aim of our study was to investigate the specific
PFC functions including response inhibition and reward
prediction in type 2 diabetes. Although it has been sug-
gested that the ventral PFC regulates momentary deci-
sion making and behavioural adjustment according to
various environmental stimuli with appropriate response
inhibition and reward prediction [2-4], the precise
effects of type 2 diabetes on such specific PFC functions
have not been fully examined. We used particular neu-
ropsychological tasks measuring response inhibition and
reward prediction for assessing the ventral PFC func-
tions, and used the Wisconsin Card Sorting Test
(WCST) which measures executive function closely
related to the dorsolateral PFC functions. This study
was performed to test the following hypotheses: 1) Mid-
dle-aged patients with type 2 diabetes have cognitive
deficits associated with the PFC, including response
inhibition and reward prediction. 2) There is an interac-




Twenty-seven patients with newly diagnosed type 2 dia-
betes and 27 healthy control subjects participated in this
study. Only male subjects were recruited to avoid the
sex differences in cognitive assessment, because
sex-related differences have been reported in several
cognitive processes, such as response inhibition [19],
emotional processing and reward expectation [20], and
working memory [21]. To avoid the influence of age,
medication, and vascular complications on cognition, we
recruited only newly diagnosed middle-aged patients
without diabetic complications who had never received
any medication for diabetes or the regular and/or inten-
sive program of lifestyle modification at the outpatient
clinic of the Diabetes Center of Tokyo Women’sM e d i -
cal University (TWMU) Hospital from July 2005 to June
2007. All patients were diagnosed with type 2 diabetes
according to the WHO definition [22]. All patients
underwent ophthalmologic assessment on study partici-
pation, and those with retinopathy were excluded
because diabetic retinopathy is a marker of brain micro-
vascular damage deteriorating PFC function [23]. Educa-
tional year-matched healthy control subjects were
recruited from among the acquaintances of hospital
staff. Inclusion criteria for all participants were as fol-
lows: age 30-59 years, right-handed, Japanese speaker
and functionally independent. Exclusion criteria for all
participants were a history of psychiatric or neurological
disorder, dementia, epilepsy, head trauma, loss of con-
sciousness, alcohol and/or substance abuse, micro- or
macro-vascular complications, including stroke or cardi-
ovascular disease, and history of regular blood pressure-
lowering treatment such as antihypertensive drugs.
To evaluate the effects of type 2 diabetes and being
overweight as independent variables, cognitive functions
were assessed in four groups: overweight patients with
type 2 diabetes, normal-weight patients with type 2 dia-
betes, overweight controls and normal-weight controls.
Height and body weight were measured and body mass
index (BMI) was calculated for each subject. According
to BMI (kg/m
2), subjects were categorised as normal
weight (18.5-24.9), overweight (25.0-29.9) or obese (≥
30). Overweight and obese subjects were analysed as a
single group because BMI ≥ 25 kg/m
2 is defined as obe-
sity in Japan based on data from body-fat percentage.
The study was performed in accordance with the
Declaration of Helsinki and approved by the Medical
Ethics Committee of Tokyo Women’s Medical Univer-
sity. All subjects gave their informed written consent to
participation in the study.
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All subjects underwent neuropsychological examination
covering specific cognitive functions. To avoid the influ-
ence of medical treatment, patients with type 2 diabetes
underwent the examination before commencement of
treatment. A trained neuropsychological assessor admi-
nistered four tests, encouraging subjects for maximum
performance, which took 60 min. The test measures
were for response inhibition, reward prediction, and
executive function.
The Go/NoGo task
Inhibitory control of impulsivity was assessed by the Go/
NoGo task [4]. The Go stimulus consisting of the letter
“N” (2/3 of all trials) and the NoGo stimulus consisting
of the letter “H” (1/3) were presented in the center of a
computer display in a random order for 100 ms with an
interstimulus interval of 2000 ms. The subjects were
instructed to press a button with the right index finger
in response to the Go stimuli as accurately and quickly
as possible, but to withhold their response if the NoGo
stimuli was presented. Errors were calculated as the
numbers of unplanned responses to the NoGo stimuli
(commission errors) and of failed responses to the Go
stimuli (omission errors). According to Signal Detection
Theory (SDT) [24], there are two kinds of errors and
those of correct responses in the Go/NoGo task: ‘false
alarms’ (incorrect ‘yes’ responses = commission errors),
‘misses’ (saying ‘no’ when it should be ‘yes’= omission
errors), ‘hits’ (correct response to the Go stimuli) and
‘correct rejection’ (correct ‘no’ response to the NoGo sti-
muli). These performance rates may vary with the task
difficulty and the subject’s response bias, so that we
calculated the z-scores of the hit and false alarm rates
by fitting those rates to the cumulative probabilities of
the normal distribution. We then calculated discrimin-
ability index (d’)a s :d ’ = z (hit rate)-z (false alarm rate)
to assess response inhibitio n[ 2 4 ] .R e s p o n s et i m ew a s
recorded for every response when pressing the button,
and the reaction time for responses to the Go stimuli
(RT) was used as a variable because it reflects the ability
of conflict monitoring [25]. Post-error slowing, which is
the reaction time on subsequent trials after unplanned
or failed responses, was also calculated because it
provides a measure of performance adjustment with
error-related feedback [26].
The reversal and extinction tasks
Ability to make advantageous actions by predicting
future rewards was assessed by the reversal and extinc-
tion tasks [3]. In the reversal task, two simple stimuli
(circle or star) randomly replaced each other on a com-
puter display, and the subjects gained points for either
responding with the correct stimulus or for not
responding with the wrong stimulus. One stimulus
remained on the display for seven seconds if there was
no response, but it disappeared immediately when a
response was made. Correct or incorrect was indicated
by a pleasant chime (reward) or an unpleasant buzzer
(punishment). After reaching nine correct responses, the
relationship between the stimuli and the consequences
was reversed without advance notice. The extinction
was similar except that it became incorrect to respond
to either stimulus after reaching nine correct responses.
The point could only be gained by refraining from
responding, while the errors were calculated as the
number of non-refrained responses in the extinction
condition.
The Wisconsin Card Sorting Test (WCST)
To assess general cognitive functions involved in execu-
tive functions, the Japanese version of the Wisconsin
Card Sorting Test (WCST) was administered [27], in
which four stimulus cards on the upper row and one
response card on the lower row were shown on a com-
puter display; the cards had geometric designs divided
into three categories: colour, form and number of sets.
The subjects were asked to decide how to categorise a
response card to the upper four cards, and to search for
the correct categorisation by trial-and-error. The
achievement scores were related to working memory.
Perseverative errors of Milner type were related to cog-
nitive shifting ability, as the errors were caused by
adhering to a former category after the classification
category had changed.
The four tests were administered in a fixed order: the
reversal task, the Go/NoGo task, the WCST and the
extinction task. The extinction task was run after the
reversal task, with a gap of at least five minutes between
the tasks.
Biomedical and emotional assessment
Blood samples were collected in the fasting state. HbA1c,
plasma glucose and plasma insulin were measured by
latex agglutination immunoassay (Fujirebio, Tokyo,
Japan), enzymatic assay with GluDH (Kanto Kagaku,
Tokyo, Japan) and radioimmunoassay using a double-
antibody/PEG technique (Eiken Kagaku, Tokyo, Japan),
respectively. The homeostasis model assessment of insu-
lin resistance (HOMA-IR) was calculated using plasma
glucose and insulin. Leptin was measured by radioim-
munoassay (Linco Method; Linco, St. Charles, MO).
Clinical depression was assessed by the major depres-
sive episode of the Mini International Neuropsychiatric
Interview (M.I.N.I.), Japanese version 5.0.0 [28] for
excluding subjects with major depressive disorders and
bipolar disorders from this study.
Statistical analyses
Demographic and biomedical data were analysed by
one-way ANOVA, and differences among groups were
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P value < 0.05 was considered significant.
Neuropsychological performance data were analysed
by two-way ANOVA with type 2 diabetes and being
overweight as between-subject factors. As age may affect
cognitive performance [29], the data were analysed by
covariate analysis of variance (ANCOVA) with age as a
covariate. One set of data in each of the extinction task
and the Go/NoGo task and two sets of data in the
WCST were not obtained due to time constraints or
technical problems. A main effect was used to deter-
mine an independent effect of type 2 diabetes or being
overweight on each performance. When both type 2 dia-
betes and being overweight showed main effects on the
same task measure without an interaction, it was consid-
ered to show the additive effect of type 2 diabetes and
being overweight. An interaction between the two fac-
tors was used to evaluate the synergistic (or cancella-
tion) effect of type 2 diabetes and being overweight. If
an interaction was found, performance data were ana-
lysed by one-way ANCOVA with age as a covariate in
each group of diabetes and being overweight. The distri-
bution was adjusted by type III sums of squares in a
revision model. When considering multiple ANCOVAs,
this analysis was based on a conservative P value (P <
0.007) calculated by the Bonferroni method with seven
neuropsychological measures, including d’, RT and post-
error slowing of the Go/NoGo task, the errors after
reversal and extinction of the reversal and extinction
tasks, and achievement scores and perseverative errors
of the WCST. For the purpose of comparing with the
results of previous studies, we also note the results sur-
viving a threshold of P < 0.05.
The additional analyses with hierarchical linear regres-
sion were performed to examine whether a neuropsy-
chological deficit, as well as biomedical changes,
contributed to glycemic control (HbA1c)i nd i a b e t i c
patients. HbA1C was the dependent variable. At step 1,
we forced the entry of the neuropsychological measures
that showed significant difference between diabetic
patients and controls. At step 2, age, BMI, plasma insu-
lin, HOMA-IR, and plasma leptin were entered and
selected by the stepwise method with P < 0.05 for entry
and retention. Statistical significance was set at P <0 . 0 5
for these additional analyses.
A l ld a t aw e r ea n a l y s e du s i n gS P S Sv e r s i o n1 2 . 0s t a t i s -
tical software (SPSS, Chicago, IL).
Results
Characteristics
The subjects’ characteristics are summarised in Table 1.
Twenty-seven subjects were of normal-weight and 27
were overweight or obese. Mean age of the subjects was
41.3 years (range 30-59), with a mean of 16.3 years of
education (range 12-20). Age was significantly different
between normal-weight patients with type 2 diabetes
and control subjects (age; normal-weight patients vs.
overweight controls, P = 0.001, normal-weight patients
vs. normal-weight controls, P < 0.001). Years of educa-
tion were not significantly different between groups.
Patients with type 2 diabetes showed higher systolic
blood pressure (systolic blood pressure; overweight
patients vs. normal-weight controls, P <0 . 0 0 1 ,n o r m a l -
weight patients vs. normal-weight controls, P = 0.009).
Overweight patients with type 2 diabetes showed appar-
ent insulin resistance (HOMA-IR; overweight patients
vs. normal-weight controls, P = 0.027), and higher
plasma leptin concentrations (leptin; overweight patients
vs. normal-weight patients, P = 0.025, overweight
patients vs. normal-weight controls, P = 0.021).
Neuropsychological performance
Table 2 shows both neuropsychological performance
data in the four groups and the results of ANCOVA
with type 2 diabetes and being overweight as between-
subject factors, and age as a covariate. No significant
correlation was observed between the results of different
neuropsychological tasks.
Type 2 diabetes showed a significant main effect on d’
in the Go/NoGo task (F(1,49) = 12.585, P = 0.001).
Patients with type 2 diabetes showed significantly
decreased response inhibition: d’ = 2.55 ± 0.14 and 3.22
± 0.10 (means ± SE) in patients and control subjects,
respectively. Additional analyses were performed to
investigate which errors of commission and omission
were more dominant for decreased response inhibition.
In the error made, type 2 diabetes showed a more
apparent main effect on commission errors (F(1,49) =
10.83, P =0 . 0 0 2 )t h a no no m i s s i o ne r r o r s( F ( 1 , 4 9 )=
4.063, P = 0.049). RT did not differ significantly between
groups. Overweight subjects showed longer post-error
slowing than normal-weight subjects: post-error slowing
= 367.7 ± 12.7 ms and 335.1 ± 10.2 ms (means ± SE) in
overweight and normal-weight subjects, respectively
(F(1,49) = 4.74, P = 0.035). RT and post-error slowing
showed significant correlation with d’ in patients with
type 2 diabetes (RT; Pearson r =0 . 5 8 2 ,P =0 . 0 0 2 ,p o s t -
error slowing; Pearson r = 0.556, P = 0.003). However,
the adjustment with RT or post-error slowing did not
change the results of two-way ANCOVA on d’ in the
Go/NoGo task (data not shown). As patients with type
2 diabetes showed higher systolic blood pressure than
normal-weight controls and higher blood pressure has
been shown to affect cognitive performance [10], the
results of diabetes-related group differences were further
controlled by ANCOVA with systolic blood pressure as
a covariate. The adjustments with systolic blood pres-
sure did not change the results of diabetes-related group
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Go/NoGo task (data not shown).
There was a significant interaction of type 2 diabetes
with being overweight on RT (F(1,49) = 7.516, P =
0.009). We thus performed stratified ANCOVAs with
age as a covariate as follows. To examine the effect of
type 2 diabetes on RT, each of normal-weight and over-
weight subjects was separately analyzed with one-way
ANCOVA with diabetes as a between-subject factor and
with age as a covariate. Next, each of diabetic and non-
diabetic subjects was separately analyzed with one-way
ANCOVA with being overweight as a between-subject
factor and with age as a covariate to examine the effect
of being overweight on RT. Type 2 diabetes showed a
trend for an effect on shorter RT for normal-weight
subjects (P = 0.062), but not for overweight subjects (P
= 0.553). Being overweight showed an effect on longer
RT for diabetic patients (P = 0.033), but not for non-
diabetic subjects (P = 0.094), suggesting that normal-
weight diabetic patients had worse performance in RT
than overweight diabetic patients. There was also a
trend for an interaction on post-error slowing (F(1,49) =
3.909, P = 0.054). Type 2 diabetes showed no effects on
post-error slowing for both normal-weight and over-
weight subjects (data not shown). Being overweight
showed an effect on longer post-error slowing for dia-
betic patients (P = 0.025), but not for non-diabetic sub-
jects (P = 0.872), suggesting similar results to RT.
In the reversal and extinction tasks, type 2 diabetes
did not show main effects on mean errors. Being over-
weight did not show a significant main effect on the
mean error after reversal. However, overweight subjects
showed continuous responding for the previously reward
stimulus in the extinction task, and the mean errors
after extinction were significantly different between
overweight and normal-weight subjects: the mean error
Table 1 Subject characteristics
OW patients NW patients OW controls NW controls
N1 6 1 1 1 1 1 6
Age (years) 42.9 ± 8.4 50.2 ± 7.1
a, b 37.0 ± 5.4
a 36.6 ± 7.9
b
Range 30-59 38-58 31-48 30-56
Education (years) 15.9 ± 1.2 16.4 ± 1.3 16.6 ± 1.1 16.8 ± 1.3
BMI (kg/m
2) 29.8 ± 4.5
c, d 23.4 ± 1.3
a, c 27.6 ± 3.8
a, e 21.7 ± 1.4
d, e
Systolic blood pressure (mmHg) 131.2 ± 9.9
d 129.6 ± 17.8
b 122.7 ± 11.2 114.2 ± 8.9
b, d
Diastolic blood pressure (mmHg) 80.6 ± 11.3 78.6 ± 8.8 82.9 ± 13.2 74.8 ± 12.2
HbA1C (%) 8.2 ± 1.6
d, f 7.6 ± 1.8
a, b 4.9 ± 0.2
a, f 4.8 ± 0.3
b, d
Plasma glucose (mmol/L) 8.4 ± 2.2
d, f 7.6 ± 1.6
a, b 5.4 ± 0.3
a, f 5.3 ± 0.3
b, d
Plasma insulin (pmol/L) 82.6 ± 70.1 44.4 ± 31.3 54.2 ± 7.6 55.6 ± 11.8
HOMA-IR 4.6 ± 4.4
d 2.2 ± 1.7 1.9 ± 0.3 1.9 ± 0.4
d
Plasma leptin (ng/ml) 7.14 ± 4.92
c, d 2.91 ± 1.47
c 5.41 ± 3.90 3.48 ± 1.55
d
Data are given as means ± SD.
a, b, c, d, e, fThere are significant differences between the groups with the same letters by Turkey-Kramer multiple comparison tests
(P < 0.05). OW, overweight; NW, normal weight.
Table 2 Neuropsychological performance of patients and control subjects
OW patients NW patients OW controls NW controls DM* OW* Interaction*
<Go/NoGo task>
Discriminability (d’) 2.66 ± 0.48 2.39 ± 1.0 3.14 ± 0.59 3.28 ± 0.46 0.001
‡ 0.648 0.215
Commission errors 9.8 ± 3.8 10.1 ± 3.8 6.6 ± 4.2 5.5 ± 2.9 0.002
‡ 0.74 0.463
Omission errors 0.4 ± 0.9 3.8 ± 8.0 0.2 ± 0.4 0.1 ± 0.3 0.049
† 0.081 0.072
RT (ms) 356 ± 28 330 ± 59 339 ± 37 363 ± 35 0.104 0.629 0.009
†
Post-error slowing (ms) 379 ± 66 322 ± 68 348 ± 57 343 ± 40 0.525 0.035
† 0.054
<Reversal and extinction tasks>
Errors after reversal 1.7 ± 3.0 1.2 ± 0.4 1.1 ± 0.3 1.0 ± 0.4 0.977 0.358 0.448
Errors after extinction 7.6 ± 3.7 6.4 ± 4.0 8.7 ± 5.2 5.1 ± 3.0 0.894 0.029
† 0.340
<WCST>
Achievement scores 5.4 ± 1.0 4.6 ± 1.3 5.9 ± 0.6 5.6 ± 0.5 0.218 0.117 0.773
% perseverative errors 2.7 ± 6.4 8.2 ± 10.1 4.2 ± 9.0 3.2 ± 5.3 0.458 0.296 0.147
Neuropsychological data are given as means ± SD. *Data were analysed by covariate analysis of variance (ANCOVA) with age as a covariate, and the main effects
and interaction of type 2 diabetes and being overweight are shown as P values.
†P<0.05,
‡P < 0.007 with ANCOVA. OW, overweight; NW, normal weight; DM,
type 2 diabetes mellitus; RT, reaction time in unplanned responses to the Go stimuli.
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SE) in overweight and normal-weight subjects, respec-
tively (F(1,49) = 5.095, P = 0.029).
In the WCST, the mean achievement scores of the
four groups were within normal limits (≥ 4) [27].
Neither type 2 diabetes nor being overweight showed
main effects or interactions on the achievement scores
and perseverative errors of the WCST.
Neuropsychological deficits and glycemic control
Patients with type 2 diabetes showed significantly
decreased response inhibition (d’) in the Go/NoGo task.
We then analyzed the effect of d’ on HbA1c with hier-
archical linear regression to examine if this neuropsy-
chological deficit contributed to glycemic control in
patients with type 2 diabetes. At step 1, we forced the
entry of d’. At step 2, age, BMI, plasma insulin, HOMA-
IR, and plasma leptin were entered and selected by the
stepwise method with P < 0.05 for entry and retention.
The d’ as well as BMI explained a significant proportion
o ft h ev a r i a n c eo fH b A 1c (R
2 = 0.287, P = 0.024, d’: b =
-0.433, P =0 . 0 2 9 ,B M I :b = 0.433, P = 0.029). Age,
plasma insulin, HOMA-IR, and plasma leptin were
excluded from the model. As patients with type 2 dia-
betes showed higher systolic blood pressure, we assessed
whether blood pressure would change the result of d’ on
HbA1c. Systolic blood pressure added to the former
model did not change the result of d’, and systolic blood
pressure was excluded from the model (data not shown).
Discussion
The main finding of this study was that inhibitory con-
trol of impulsive responses was decreased in newly diag-
nosed middle-aged patients with type 2 diabetes. The
Go/NoGo task is commonly used to assess the ability to
inhibit impulsive responses, as poor performance in this
task presents as rapid, unplanned reactions to environ-
mental stimuli without regard to negative consequences
of these reactions [4,30]. The Go/NoGo task has good
test-retest reliability [31] and provides several indices of
response inhibition, such as the error made and the
reaction times (RT and post-error slowing) [25,26]. In
this study, we calculated discriminability index (d’)f r o m
hits and false alarm rates to estimate the task difficulty
considering the subject’s response bias. As expected, d’
was significantly decreased in patients with type 2 dia-
betes. Further, we found that decreased d’ was signifi-
cantly associated with increased HbA1C in diabetic
patients, suggesting the lack of inhibitory control may
be related to the aggravation of type 2 diabetes. Addi-
tional analysis indicated a greater difference in the num-
ber of commission errors than in omission errors
between diabetic patients and controls in the Go/NoGo
task. The increase in commission errors suggests failure
of impulsivity control despite both knowledge of adverse
consequences and a desire to quit [4,30,31]. Several stu-
dies have indicated a significant correlation between
self-reported impulsivity and increased commission
errors in the Go/NoGo task [32,33]. In patients with
diabetes, temptation to eat is frequently cued by specific
people (e.g., a friend always carrying sweets), place (e.g.,
a particular shop) and events (e.g., parties). Appropriate
behavior modification thus depends on the patient’s
ability to inhibit impulsive thoughts and actions cued by
these environmental stimuli. As this was a cross-sec-
tional study, we cannot make any definitive conclusions
regarding a causal relationship. However, our study
included only newly diagnosed patients with type 2 dia-
betes, suggesting the possibility that the neuropsycholo-
gical deficits in response inhibition may contribute to
the behavioral problems leading to chronic lifestyle-
related diseases, such as type 2 diabetes. It is also possi-
ble that the metabolic changes with diabetes affect brain
functions and cause neuropsychological deficits [7,8].
Several studies indicated that metabolic improvement
resulted in improved cognitive function in people with
type 2 diabetes [9,34]. Further longitudinal studies will
be useful to detect progression or improvement of neu-
ropsychological deficits associated with metabolic
changes.
A Previous study [10] demonstrated that diabetes-
related difference was apparent in the selective cognitive
domain requiring a contribution of speed and response
inhibition in older patients with type 2 diabetes. They
demonstrated a significant decrease in response inhibi-
tion across the two late-life age groups in young-old and
old-old subjects (mean age and range: young-old, 63.64,
55-69 years old; old-old, 75.59, 71-80 years old), using
the Hayling test and Color Trails 2 task. We confirmed
their findings with regard to the abnormality of response
inhibition using the Go/NoGo task in younger patients
(mean age and range: 45.89, 30-59 years old) than in
their study. We included only patients with newly diag-
nosed type 2 diabetes according to the WHO definition
and with no diabetic complications. Therefore, our
patient characteristics reduced the influence of cognitive
decline associated with age, disease duration-related
brain damage [6,11] and the effects of medication
[12,13] in type 2 diabetes. It is important to note that
both Yeung et al. [10] and the present study found simi-
lar relations between diabetes and response inhibition
abnormality in different patient populations, which
strongly supports the suggestion that the deficit in the
cognitive domain of response inhibition may be a parti-
cular manifestation of diabetes-associated cognitive dys-
function that is robust across different age groups.
With regard to the contribution of speed to response
inhibition, the possible influence of the subject’s motor
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ment after committing errors should be addressed
[25,30]. With regard to motor performance, Hershey et
al. demonstrated decreased d’ in the Go/NoGo task in
Parkinson disease patients with improved motor perfor-
mance due to subthalamic nucleus stimulation [35], sug-
gesting that response inhibition cannot be explained
easily by changes in motor performance. As previous
studies of type 2 diabetes indicated no impairments in
simple motor function assessed by the simple reaction
time [7,10] or Trail Making Test A [8], it is unlikely
that simple motor function made the main contribution
to the present results. Next, the results of RT and post-
error slowing reflect the ability of conflict monitoring
and performance adjustment with error-related feedback
in the Go/NoGo task [25,26]. Consistent with the pre-
vious findings that longer RT and post-error slowing is
related to better performance adjustment with appropri-
ate error monitoring [25,36], RT and post-error slowing
was positively related to better performance (increased
d’) in patients with type 2 diabetes in the present study.
However, the results of group comparison of d’ did not
change after adjustment with RT or post-error slowing,
suggesting that the decreased response inhibition in dia-
betic patients may relate to the different neurological
function from error monitoring and adjustments. We
found significant decrease in d’ but not in RT and post-
error slowing in patients with type 2 diabetes. Kaiser et
al. also reported decreased d’ but similar RT in patients
with major depression, with the findings of reduced
event-related potential in the frontal lobe in patients
with decreased d’, suggesting that specific impairment of
impulsivity control is associated with PFC dysfunction
in depressive patients [37]. RT and post-error slowing
were reported to reflect anterior cingulate cortex (ACC)
function [25,26,36]. A previous study using functional
magnetic resonance imaging demonstrated dissociated
roles of ACC and PFC in response inhibition, such that
ACC function is engaged when an ongoing action needs
to be quickly changed and PFC function is more impor-
tant in changing attitudes toward future consequences
[38]. These findings support the possibility that the inhi-
bitory failure observed in diabetic patients could be
mainly explained by cognitive impairment of impulsivity
control associated with PFC function rather than by def-
icits in motor performance, error monitoring and
adjustment.
The results of RT and post-error slowing suggested
that there may be interactive effects of type 2 diabetes
with being overweight on reaction times in the Go/
NoGo task. The direction of interactions on RT and
post-error slowing was different from our prediction.
RT and post-error slowing were shorter in normal-
weight patients than in overweight patients with type 2
diabetes, whereas these reaction times were not different
between normal-weight and overweight non-diabetic
control subjects. We assumed that one of the major dif-
ferences between normal-weight and overweight patients
with type 2 diabetes was the ability of insulin secretion
[18]. Normal-weight patients with type 2 diabetes
showed low plasma insulin concentration, whereas over-
weight patients with type 2 diabetes showed apparent
insulin resistance and high plasma insulin concentration.
Previous studies suggested that insulin resistance is a
determinant of free fatty acids which are important in
tryptophan metabolism and brain serotonin concentra-
tions, and that overweight subjects who are insulin resis-
tant may have higher brain serotonin concentration
[39,40]. On the other hand, normal-weight diabetic
patients with insulin deficiency may have reduced brain
s e r o t o n i na c t i v i t y[ 4 1 ]a n dm a yb em o r ei m p u l s i v et h a n
overweight patients with type 2 diabetes. Brain serotonin
concentration level was reported to affect ACC activa-
tion during the Go/Nogo task [42], and these findings
are consistent with the present results. However, there
have been conflicting results with regard to ACC func-
tion in type 2 diabetes [43,44]. One study reported atte-
nuated ACC activation [43] and the other did not find
differential ACC activation between patients with type 2
diabetes and controls [44]. These previous studies
[43,44] did not indicate the BMI of the subjects nor
compare overweight and normal-weight patients with
type 2 diabetes, which made it difficult to evaluate an
interaction of being overweight with type 2 diabetes on
ACC function, and this issue should be confirmed in
further studies.
We also found that overweight and obese subjects
showed significant performance difference in errors after
extinction in the extinction task. Overweight and obese
subjects retained responses to stimuli showing the pre-
sentiment of reward after the extinction condition of the
former reward in the extinction task although the result
did not survive a conservative P value. Overweight and
obese subjects had difficulty in refraining from inap-
propriate responses and their behavior seemed guided
by previous experiences of reward, which is consistent
with the results of a previous study that indicated deci-
sion-making deficits with addictive reward-seeking in
obesity [14]. It is increasingly recognized that much of
excess caloric intake in obesity is driven by the reward-
ing properties of palatable food [45]. People learn asso-
ciations between environmental stimuli (e.g. a box
contains palatable food) and the reinforcement value
(reward with innate pleasure), and hedonic factors such
a st a s t ea n dt h em e m o r i z e dr e w a r dm a yp l a yal a r g e
role in continuous food consumption even after energy
homeostasis has been fulfilled. Increased errors in the
extinction task suggest a failure in breaking previously
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value [3]. Therefore, overweight and obese subjects may
have difficulties in correcting their food consumption
when the reinforcement value of the stimuli has chan-
ged (e.g. adverse physical outcome by taking palatable
food), which will result in a failure of dietary improve-
ment and further weight gain. However, the degree of
obesity in our subjects was lower than in several pre-
vious studies indicating relation of cognitive decline
with BMI [46,47], which may have been responsible for
our limited findings. Further studies of larger numbers
of obese subjects are needed to investigate this relation.
The present results regarding working memory and
executive function were markedly different from those
of previous studies that suggested significant impairment
of executive function in subjects with type 2 diabetes
[6-9] or overweight subjects [46,47]. The mean achieve-
ment scores of the WCST were all within normal limits
(≥ 4) and the perseverative errors were not different
among the groups. Although a previous neuropsycholo-
gical study indicated that the achievement scores of the
WCST were negatively correlated with the number of
commission errors in the Go/NoGo task [48], there
were no associations of the WCST variables with the
results of the Go/NoGo task or the extinction task.
Therefore, the poorer performance in these tasks cannot
be attributed to reduced executive function. The normal
p e r f o r m a n c ei nt h eW C S Tm a yh a v eb e e nd u et ot h e
subjects’ age and high educational background in this
study, because higher age and lower education level
have lowering effects on the WCST [27,49]. A previous
study indicated that the WCST score is strongly asso-
ciated with age-related cortical atrophy and white matter
lesions (WMLs) in the PFC [50]. It is possible that
newly diagnosed middle-aged patients with no complica-
tions do not have marked cognitive decline associated
with age or disease duration-related brain damage [6].
This study had the following strengths. First, we
assessed cognitive performance in the four groups and
analysed performance data using two-way ANOVA with
diabetes and overweight as factors, which allowed us to
find specific cognitive dysfunction in type 2 diabetes.
Second, we studied younger subjects than those
included in previous studies [6-10] with exclusion of
diabetic vascular complications, which helped reduce
the influence of age and vascular cognitive decline in
assessing the cognitive functions. Third, we recruited
newly diagnosed and medication-free patients, which
allowed us to exclude the effects of oral medication [12]
and exogenous insulin [13] in assessing the cognitive
functions.
There were several limitations in the study. First, the
study population included only men because men and
women show important differences in clinical conditions
in which cognitive deficits are implicated. Several studies
have reported sex-related differences in response inhibi-
tion [19,51], reward expectation [20], and working mem-
ory [21]. However, especially in response inhibition,
there have been conflicting reports suggesting no differ-
ence in behavioral and brain-functional results in the
Go/NoGo task [25]. Although menstruation and preg-
nancy should be carefully excluded [21], further studies
including middle-aged women will provide more infor-
mation on the cognitive function associated with the
Go/NoGo task. Second, the results should be considered
carefully for multiple ANCOVAs. Based on a conserva-
tive P value (P < 0.007), only the results of decreased
inhibitory control in patients with type 2 diabetes
remained significant. Third, the degree of obesity in our
subjects was lower than in several previous studies indi-
cating obesity-related cognitive decline [46,47], which
may have been responsible for our limited findings.
Further studies comparing a more severely obese group
and non-obese group with or without diabetes would be
helpful to find specific and interactive cognitive deficits
between obesity and diabetes. Finally, we cannot defi-
nitely conclude there were any causal relationships as
this was a cross-sectional study.
Conclusion
In conclusion, this study revealed a particular neuropsy-
chological deficit, i.e., difficulty in inhibitory control of
impulsive responses in middle-aged, newly diagnosed
type 2 diabetes with or without being overweight, the
clinical significance of which remains to be investigated
in future studies.
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